/Investor DB

Connecticut Innovations — 2020 Investments

5 investments dated 2020 · listed companies and verified rows first · show all

Azitraazitrainc.comNYSE: AZTROct 2020 · $17M

Azitra is a clinical-stage biopharmaceutical company developing genetically engineered bacteria and proteins for treating skin diseases through precision dermatology.

AI & Machine LearningBiotechHealthtechFarmington, US

Francisco D. Salva(President and Chief Executive Officer)inAzim Munivar(Executive Officer, Director, Promoter)

BoardStella Robertson(Director)inTravis Whitfill(Executive Officer, Director, Promoter)in

Co-investorsBios PartnersKdT VenturesLeaps by Bayer

Diameter Healthavaility.comin𝕏Sep 2020 · $18MAcquired

Availity is a healthcare network platform that processes eligibility, authorizations, claims, and payment transactions for providers, payers, and healthcare IT vendors.

AI & Machine LearningEnterprise SoftwareHealthtechFarmington, US

John D'Amore(Executive Officer, Director, Promoter)Eric Rosow(Executive Officer, Director, Promoter)Russ ThomasinRichard Dumler(Director)

BoardMatthew D. Storeygard(Director)in

Co-investorsExcelerate Health VenturesHLM Investment PartnersLRVHealthActivate Venture PartnersOptum Ventures

FinTronfintroninvest.com𝕏Nov 2020

Stamford, US

Wilder Rumpf(Founder)in

Co-investorsAUA Capital ManagementSage Venture PartnersWebster Bank

Intelliboardintelliboard.netin𝕏Series A · May 2020 · $3M

IntelliBoard provides learning analytics solutions for educational institutions, offering a platform that integrates data from learning management systems and brings together data into analytics dashboards.

AI & Machine LearningData & InfrastructureEdTechEnterprise SoftwareSaaS

Co-investorsLeta CapitalFlashpoint Venture Capital

ReferWellreferwell.comin𝕏Mar 2020

ReferWell provides referral management and appointment scheduling technology combined with expert care navigators to help health plans and providers close care gaps and get members to their appointments.

Digital HealthHealthtechSaaSStamford, US

Co-investorsHealth Catalyst Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.